November 2023 Medical News Summary

Why Physicians Don’t Deprescribe Medicines; What to Know About Wegovy’s Rare but Serious Adverse Effects; What to Know About Zepbound, the Newest Antiobesity Drug

Related Content:

As Semaglutide’s Popularity Soars, Rare but Serious Adverse Effects Are Emerging
FDA Green-Lights Tirzepatide, Marketed as Zepbound, for Chronic Weight Management
Deciding When It’s Better to Deprescribe Medicines Than to Continue Them

2356 232

November 2023 Medical News Summary2 years ago

12:18

Suggested Podcasts

The MR PORTER Podcast | The Details

Project Management Podcast: Project Management for the Masses with Cesar Abeid, PMP

Industry Focus

The Moby-Dick Big Read

Utilitarianism by John Stuart Mill

The Workshop is in the Mind

Evil Thoughts

Culture Apothecary with Alex Clark

cedzxtech

Katha Sangama

Download the app

Get it on Google Play Available on the App Store

lystn

November 2023 Medical News Summary

Suggested Podcasts

Please complete your sign-in

Download the app